Fidia Issues 2 Million New Shares After Partial Bond Conversion

An update from Fidia Spa ( (IT:FDA) ) is now available.

Fidia S.p.A., a Turin‑based provider of numerical controls, high‑speed milling systems and CAM software for complex shapes, serves mainly the automotive mould and aerospace sectors and is recognized as one of the few players able to cover the entire milling process from programming to finished product. The company leverages over five decades of expertise and a workforce of around 135 employees to support customers worldwide with integrated hardware and software solutions.

Fidia announced that Global Growth Holding Limited has converted two bonds from the fourth tranche of its reserved convertible bond with warrants, resulting in the issuance of 2,000,000 new shares at a conversion price of €0.01 per share. Following this partial conversion, the company’s share capital rises by €20,000 to €10,797,761.90, the total share count increases to 54,542,927, the POC has been subscribed for a nominal €1,000,000 with €950,000 of related capital increase executed, and five bonds remain subscribed but not yet converted, modestly advancing Fidia’s ongoing financing plan and share capital strengthening.

The most recent analyst rating on (IT:FDA) stock is a Sell with a EUR0.11 price target. To see the full list of analyst forecasts on Fidia Spa stock, see the IT:FDA Stock Forecast page.

More about Fidia Spa

Fidia S.p.A., based in Turin and listed on Euronext Milan, is a specialist in numerical control technology and high‑performance integrated milling systems used primarily in the mould sector for the automotive industry and in aerospace applications. With more than 50 years of experience and about 135 employees, the group offers end‑to‑end milling solutions, from machining program definition to finished parts, including numerical controls, high‑speed milling machines and CAM software for complex shapes.

YTD Price Performance: -85.00%

Average Trading Volume: 1,478,265

Technical Sentiment Signal: Strong Sell

Current Market Cap: €545.2K

For a thorough assessment of FDA stock, go to TipRanks’ Stock Analysis page.